Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liver resection and transplantation for intrahepatic cholangiocarcinoma
Vincenzo Mazzaferro, Andre Gorgen, Sasan Roayaie, et al.
Journal of Hepatology (2020) Vol. 72, Iss. 2, pp. 364-377
Open Access | Times Cited: 273

Showing 1-25 of 273 citing articles:

Biliary tract cancer
Juan W. Valle, Robin Katie Kelley, Bruno Nervi, et al.
The Lancet (2021) Vol. 397, Iss. 10272, pp. 428-444
Closed Access | Times Cited: 670
EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma
Domenico Alvaro, Gregory J. Gores, Joël Walicki, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 1, pp. 181-208
Open Access | Times Cited: 132
Clinical treatment of cholangiocarcinoma: an updated comprehensive review
Alessandra Elvevi, Alice Laffusa, Miki Scaravaglio, et al.
Annals of Hepatology (2022) Vol. 27, Iss. 5, pp. 100737-100737
Open Access | Times Cited: 92
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data
Margherita Rimini, Lorenzo Fornaro, Sara Lonardi, et al.
Liver International (2023) Vol. 43, Iss. 8, pp. 1803-1812
Open Access | Times Cited: 62
Long-Term Outcomes According to Surgical Margin in Mass-Forming Cholangiocarcinoma: The Role of R1vasc
Flavio Milana, Fabio Procopio, Eleonora Calafiore, et al.
Annals of Surgical Oncology (2025)
Closed Access | Times Cited: 2
Surgical Treatments of Hepatobiliary Cancers
Ganesh Gunasekaran, Yuki Bekki, Vennis Lourdusamy, et al.
Hepatology (2020) Vol. 73, Iss. S1, pp. 128-136
Closed Access | Times Cited: 138
Survival following liver transplantation for locally advanced, unresectable intrahepatic cholangiocarcinoma
Robert McMillan, Milind Javle, Sudha Kodali, et al.
American Journal of Transplantation (2021) Vol. 22, Iss. 3, pp. 823-832
Open Access | Times Cited: 79
PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival
Francesco Fiz, Chiara Masci, Guido Costa, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 10, pp. 3387-3400
Closed Access | Times Cited: 56
Treatment of Intrahepatic Cholangiocarcinoma—A Multidisciplinary Approach
Felix Krenzien, Nora Nevermann, Alina Krombholz, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 362-362
Open Access | Times Cited: 54
Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma
Carlo Sposito, Francesca Ratti, Alessandro Cucchetti, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 2, pp. 356-363
Closed Access | Times Cited: 54
YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation
Chen‐Song Huang, Ying‐Qin Zhu, Qiong‐Cong Xu, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 6
Open Access | Times Cited: 47
Noninvasive prediction of perineural invasion in intrahepatic cholangiocarcinoma by clinicoradiological features and computed tomography radiomics based on interpretable machine learning: a multicenter cohort study
Ziwei Liu, Chun Luo, Xinjie Chen, et al.
International Journal of Surgery (2023)
Open Access | Times Cited: 28
New Challenges in the Management of Cholangiocarcinoma: The Role of Liver Transplantation, Locoregional Therapies, and Systemic Therapy
Ezequiel Mauro, Joana Ferrer, Tamara Saurí, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1244-1244
Open Access | Times Cited: 25
Current Status and Analysis of Machine Learning in Hepatocellular Carcinoma
Sijia Feng, Jianhua Wang, Liheng Wang, et al.
Journal of Clinical and Translational Hepatology (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 25
Clinical management of intrahepatic cholangiocarcinoma: surgical approaches and systemic therapies
Samantha M. Ruff, Timothy M. Pawlik
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 12
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population
Margherita Rimini, Lorenzo Fornaro, Mario Domenico Rizzato, et al.
European Journal of Cancer (2024) Vol. 208, pp. 114199-114199
Closed Access | Times Cited: 12
Microwave ablation versus liver resection for primary intrahepatic cholangiocarcinoma within Milan criteria: a long-term multicenter cohort study
Chuan Pang, Jianming Li, Jianping Dou, et al.
EClinicalMedicine (2024) Vol. 67, pp. 102336-102336
Open Access | Times Cited: 9
Multiomic Analysis Reveals Comprehensive Tumor Heterogeneity and Distinct Immune Subtypes in Multifocal Intrahepatic Cholangiocarcinoma
Shuling Chen, Yubin Xie, Yuhong Cai, et al.
Clinical Cancer Research (2021) Vol. 28, Iss. 9, pp. 1896-1910
Open Access | Times Cited: 45
Normothermic Machine Perfusion for Declined Livers: A Strategy to Rescue Marginal Livers for Transplantation
Franklin Olumba, Fangyu Zhou, Yikyung Park, et al.
Journal of the American College of Surgeons (2023)
Closed Access | Times Cited: 17
CircZNF215 promotes tumor growth and metastasis through inactivation of the PTEN/AKT pathway in intrahepatic cholangiocarcinoma
Wenwei Liao, Jinpeng Du, Lian Li, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 17
Intrahepatic cholangiocarcinoma: Evolving strategies in management and treatment
Maria Consiglia Bragazzi, Rosanna Venere, Emanuela Ribichini, et al.
Digestive and Liver Disease (2023) Vol. 56, Iss. 3, pp. 383-393
Closed Access | Times Cited: 17
Tumor-infiltrating T lymphocytes: A promising immunotherapeutic target for preventing immune escape in cholangiocarcinoma
Sijia Hua, Xinyi Gu, Hangbin Jin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117080-117080
Open Access | Times Cited: 8
Cholangiocarcinoma: The Current Status of Surgical Options including Liver Transplantation
Abdullah Esmail, Mohamed Badheeb, Batool Wael Alnahar, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 1946-1946
Open Access | Times Cited: 7
Driver mutations of intrahepatic cholangiocarcinoma shape clinically relevant genomic clusters with distinct molecular features and therapeutic vulnerabilities
Xiangyu Wang, Wenwei Zhu, Zheng Wang, et al.
Theranostics (2021) Vol. 12, Iss. 1, pp. 260-276
Open Access | Times Cited: 36
The role of lymphadenectomy in the surgical treatment of intrahepatic cholangiocarcinoma: A review
Carlo Sposito, Michele Droz Dit Busset, Matteo Virdis, et al.
European Journal of Surgical Oncology (2021) Vol. 48, Iss. 1, pp. 150-159
Closed Access | Times Cited: 35
Page 1 - Next Page

Scroll to top